HAMLET triggers apoptosis but tumor cell death is independent of caspases, Bcl-2 and p53

Apoptosis : an International Journal on Programmed Cell Death
Oskar HallgrenCatharina Svanborg

Abstract

HAMLET (Human alpha-lactalbumin Made Lethal to Tumor cells) triggers selective tumor cell death in vitro and limits tumor progression in vivo. Dying cells show features of apoptosis but it is not clear if the apoptotic response explains tumor cell death. This study examined the contribution of apoptosis to cell death in response to HAMLET. Apoptotic changes like caspase activation, phosphatidyl serine externalization, chromatin condensation were detected in HAMLET-treated tumor cells, but caspase inhibition or Bcl-2 over-expression did not prolong cell survival and the caspase response was Bcl-2 independent. HAMLET translocates to the nuclei and binds directly to chromatin, but the death response was unrelated to the p53 status of the tumor cells. p53 deletions or gain of function mutations did not influence the HAMLET sensitivity of tumor cells. Chromatin condensation was partly caspase dependent, but apoptosis-like marginalization of chromatin was also observed. The results show that tumor cell death in response to HAMLET is independent of caspases, p53 and Bcl-2 even though HAMLET activates an apoptotic response. The use of other cell death pathways allows HAMLET to successfully circumvent fundamental anti-apoptotic strategi...Continue Reading

References

Oct 1, 1990·Molecular and Cellular Biology·J Cheng, M Haas
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·A HåkanssonC Svanborg
Nov 4, 1994·Science·S W LoweT Jacks
Jul 1, 1994·Infection and Immunity·A HåkanssonC Svanborg
Jul 1, 1993·Experimental Cell Research·B ZhivotovskyS Orrenius
Apr 29, 1993·Nature·D P Lane
Apr 16, 1998·The Journal of Biological Chemistry·L MonneyC Borner
Aug 28, 1998·Science·D R Green, J C Reed
Mar 5, 1999·Cellular and Molecular Life Sciences : CMLS·S Bates, K H Vousden
Jun 15, 1999·Experimental Cell Research·C KöhlerB Zhivotovsky
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J C Reed
Apr 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·M SvenssonC Svanborg
May 10, 2000·Nature Medicine·G Kroemer, J C Reed
Aug 3, 2001·Nature Reviews. Molecular Cell Biology·M Leist, M Jäättelä
Dec 12, 2001·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·M YamakiM Horikoshi
Mar 5, 2002·Nature Medicine·Vladimir J N BykovGalina Selivanova
Jun 18, 2002·The Journal of Biological Chemistry·John D RobertsonSten Orrenius
Jun 20, 2002·The Journal of Biological Chemistry·Ida Stenfeldt MathiasenMarja Jäättelä
Jan 14, 2003·Annals of Medicine·Marja Jäättelä
Apr 30, 2003·Nature Immunology·Marja Jäättelä, Jürg Tschopp
Jun 26, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Verena JendrossekClaus Belka
Jul 31, 2003·The Journal of Biological Chemistry·Caroline DüringerCatharina Svanborg
Jun 25, 2004·The New England Journal of Medicine·Lotta GustafssonCatharina Svanborg

❮ Previous
Next ❯

Citations

May 19, 2009·The Journal of Dairy Research·Coloma PocovíLourdes Sánchez
Sep 13, 2007·Annual Review of Pharmacology and Toxicology·Claude BackendorfMathieu Noteborn
Mar 17, 2011·PloS One·Maria TrulssonCatharina Svanborg
Mar 23, 2011·PloS One·Anders P HakanssonCatharina Svanborg
Nov 8, 2012·Future Oncology·James Ho C SCatharina Svanborg
Nov 6, 2008·Annals of Medicine·Jenny Pettersson-KastbergCatharina Svanborg
Feb 9, 2010·Trends in Molecular Medicine·Stefan Grimm, Mathieu Noteborn
Dec 3, 2008·International Journal of Cancer. Journal International Du Cancer·Sonja AitsCatharina Svanborg
Oct 28, 2010·The FEBS Journal·Ann-Kristin MossbergCatharina Svanborg
Feb 28, 2013·The FEBS Journal·Christel R BrinkmannDaniel E Otzen
Jan 16, 2007·Biochemical and Biophysical Research Communications·K Hun MokCatharina Svanborg
Jul 24, 2012·Biochemical Society Transactions·Soyoung MinK Hun Mok
Feb 22, 2012·Journal of Molecular Biology·Anne BaumannOyvind Halskau
Dec 26, 2013·Biochimica Et Biophysica Acta·Bing FangFa Zheng Ren
Mar 19, 2013·Biochimica Et Biophysica Acta·Angelo FontanaPatrizia Polverino de Laureto
Aug 23, 2020·Biomolecules·Eugene A Permyakov
Nov 14, 2018·Antimicrobial Agents and Chemotherapy·Virginia MeikleMichael Niederweis
Apr 25, 2018·The Protein Journal·Esmail M El-FakharanyElrashdy M Redwan
Jan 8, 2010·Molecular Cancer Therapeutics·Paul RammerMarja Jäättelä
Dec 7, 2007·Cancer Research·Patrick BrestCatharina Svanborg
Jul 23, 2020·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Nicoleta SineviciJeff O'Sullivan

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

The Journal of Biological Chemistry
Caroline DuringerCatharina Svanborg
International Journal of Cancer. Journal International Du Cancer
Ann-Kristin MossbergCatharina Svanborg
Proceedings of the National Academy of Sciences of the United States of America
M SvenssonCatharina Svanborg
The New England Journal of Medicine
Lotta GustafssonCatharina Svanborg
© 2021 Meta ULC. All rights reserved